Studies

The International Mesothelioma Program (IMP) at Brigham and Women’s Hospital in Boston has already made significant progress in developing new treatments to extend the lives of mesothelioma patients.  Under the leadership of Dr. David Sugarbaker, the specialists at the IMP [...]

One of the most significant problems in the treatment of malignant mesothelioma is that the tumor can be resistant to many traditional forms of chemotherapy drugs.  This drug resistance varies from patient to patient.  Hence, weeks and even months of [...]

As you or your loved one is considering the course of treatment for mesothelioma, you and your physician will need to explore the possibility of enrolling in a clinical trial as a critically important option.  A clinical trial is a [...]

When faced with a life-threatening diagnosis of malignant mesothelioma, the patient and his or her loved ones will certainly seek the most advanced medical care to ensure the best possible outcome.  Memorial Sloan-Kettering Cancer Center is at the forefront of [...]